[HTML][HTML] A review of AI-based radiomics and computational pathology approaches in triple-negative breast cancer: current applications and perspectives
G Corredor, S Bharadwaj, T Pathak… - Clinical Breast …, 2023 - Elsevier
Breast cancer is one of the most common and deadly cancers worldwide. Approximately,
20% of all breast cancers are characterized as triple negative (TNBC). TNBC typically is …
20% of all breast cancers are characterized as triple negative (TNBC). TNBC typically is …
Understanding breast cancer aggressiveness and its implications in diagnosis and treatment
N Afifi, CA Barrero - Journal of Clinical Medicine, 2023 - mdpi.com
Breast cancer (BC) is the most common form of cancer in women worldwide. BC
aggressiveness is associated with metastasis, relapse, and high mortality rates. The …
aggressiveness is associated with metastasis, relapse, and high mortality rates. The …
Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential …
Y Zhang, C You, Y Pei, F Yang, D Li, Y Jiang… - Journal of Translational …, 2022 - Springer
Background We established a radiogenomic model to predict pathological complete
response (pCR) in triple-negative breast cancer (TNBC) and explored the association …
response (pCR) in triple-negative breast cancer (TNBC) and explored the association …
Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
MS Elizabeth, CG Christian - Mini Reviews in Medicinal …, 2024 - ingentaconnect.com
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks
estrogen and progesterone receptors and does not overexpress the human epidermal …
estrogen and progesterone receptors and does not overexpress the human epidermal …
Dimethyl Fumarate Induces Apoptosis via Inhibition of NF-κB and Enhances the Effect of Paclitaxel and Adriamycin in Human TNBC Cells
Triple-negative breast cancer (TNBC) has the poorest prognosis of all breast cancer
subtypes. Recently, the activation of NF-κB, which is involved in the growth and survival of …
subtypes. Recently, the activation of NF-κB, which is involved in the growth and survival of …
[HTML][HTML] Adaptive radiotherapy for breast cancer
C De-Colle, A Kirby, N Russell, SF Shaitelman… - Clinical and …, 2023 - Elsevier
Research in the field of local and locoregional breast cancer radiotherapy aims to maintain
excellent oncological outcomes while reducing treatment-related toxicity. Adaptive …
excellent oncological outcomes while reducing treatment-related toxicity. Adaptive …
Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer
C Chapa, E Meléndez-Solano… - Instituto de Ingeniería y …, 2023 - cathi.uacj.mx
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks
estrogen and progesterone receptors and does not overexpress the human epidermal …
estrogen and progesterone receptors and does not overexpress the human epidermal …
[PDF][PDF] Clinical and Translational Radiation Oncology
C De-Colle, A Kirby, N Russell, SF Shaitelman… - 2017 - researchinformation.umcutrecht.nl
Research in the field of local and locoregional breast cancer radiotherapy aims to maintain
excellent oncological outcomes while reducing treatment-related toxicity. Adaptive …
excellent oncological outcomes while reducing treatment-related toxicity. Adaptive …
[PDF][PDF] 乳がんにおける新規治療法の開発とがん化学療法における支持療法に関する臨床的研究
鶴島克将， ツルシマカツマサ - 博士学位論文/本文(令和4 年度授与), 2023 - kindai.repo.nii.ac.jp
乳がんは世界的にも罹患者数の多いがんであり, 日本においても女性のがん罹患者数で第 1
位となっている. 乳がんは乳腺の組織にできる悪性腫瘍であり, 多くは乳管から発生し …
位となっている. 乳がんは乳腺の組織にできる悪性腫瘍であり, 多くは乳管から発生し …